{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:01:03Z","timestamp":1780509663335,"version":"3.54.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ijcard.2020.10.063","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T12:33:19Z","timestamp":1603715599000},"page":"131-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis"],"prefix":"10.1016","volume":"324","author":[{"given":"Giacomo","family":"Veronese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Ammirati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Klingel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Maisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houjuan","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Tschope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie T.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2020.10.063_bb0005","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11886-018-1054-z","article-title":"Acute and fulminant myocarditis: a pragmatic clinical approach to diagnosis and treatment","volume":"20","author":"Ammirati","year":"2018","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0010","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000745","article-title":"Recognition and initial management of Fulminant Myocarditis: a scientific statement from the American Heart Association","volume":"141","author":"Kociol","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.10.063_bb0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11427-018-9385-3","article-title":"Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis","volume":"62","author":"Wang","year":"2019","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0020","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/CIRCRESAHA.118.313578","article-title":"Management of myocarditis-related cardiomyopathy in adults","volume":"124","author":"Tschope","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0025","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","author":"Tsch\u00f6pe","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0030","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s00380-017-0960-0","article-title":"Factors and values at admission that predict a fulminant course of acute myocarditis: data from Tokyo CCU network database","volume":"32","author":"Inaba","year":"2017","journal-title":"Heart Vessel."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0035","article-title":"Update on acute myocarditis","author":"Ammirati","year":"2020","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","article-title":"Management of acute myocarditis and chronic inflammatory cardiomyopathy","author":"Ammirati","year":"2020","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0045","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIRCULATIONAHA.117.026386","article-title":"Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis","volume":"136","author":"Ammirati","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.10.063_bb0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacc.2019.04.063","article-title":"Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction","volume":"74","author":"Ammirati","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11427-018-9501-9","article-title":"A life support-based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis: a multiple center study","volume":"62","author":"Li","year":"2019","journal-title":"Sci. China Life Sci."},{"issue":"10","key":"10.1016\/j.ijcard.2020.10.063_bb0060","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1056\/NEJM200003093421003","article-title":"Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis","volume":"342","author":"McCarthy","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0065","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/eurheartj\/ehp249","article-title":"Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study","volume":"30","author":"Frustaci","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0070","article-title":"Corticosteroids for viral myocarditis","volume":"10","author":"Chen","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0075","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ccc.2013.03.004","article-title":"Fulminant myocarditis","volume":"29","author":"Ginsberg","year":"2013","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0080","first-page":"279","article-title":"Fulminant myocarditis: characteristics, treatment, and outcomes","volume":"19","author":"Veronese","year":"2018","journal-title":"Anatol. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0085","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11684-019-0713-9","article-title":"Temporal echocardiography findings in patients with fulminant myocarditis: beyond ejection fraction decline","volume":"14","author":"Zuo","year":"2019","journal-title":"Front Med."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11427-018-9385-3","article-title":"Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis","volume":"62","author":"Wang","year":"2019","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0095","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11427-018-9445-2","article-title":"China\u2019s treatment regimen for fulminant myocarditis is bringing wonderful achievement to the world","volume":"62","author":"Zhang","year":"2019","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11427-019-9507-x","article-title":"An improved protocol for the treatment of fulminant myocarditis","volume":"62","author":"Edin","year":"2019","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0105","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/CIRCULATIONAHA.118.035319","article-title":"Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis","volume":"138","author":"Ammirati","year":"2018","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0110","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Europ. Heart J."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0115","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1253\/circj.CJ-88-0008","article-title":"Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version","volume":"75","author":"JCS Joint Working Group","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0120","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJM199706263362603","article-title":"Idiopathic giant-cell myocarditis\u2014natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators","volume":"336","author":"Cooper","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0125","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/CIRCHEARTFAILURE.112.000087","article-title":"Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000-2009","volume":"6","author":"Bennett","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0130","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.mayocp.2016.05.013","article-title":"Myocarditis in clinical practice","volume":"91","author":"Sinagra","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0135","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.107.186093","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology","volume":"116","author":"Cooper","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.10.063_bb0140","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0735-1097(03)00648-X","article-title":"Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults","volume":"42","author":"Bowles","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0145","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMc0911362","article-title":"Human parvovirus B19-associated myocarditis","volume":"362","author":"Bock","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0150","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/ejhf.665","article-title":"Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature","volume":"18","author":"Verdonschot","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCHEARTFAILURE.110.958249","article-title":"Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure","volume":"4","author":"Stewart","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0160","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/CIRCRESAHA.115.306573","article-title":"Myocarditis","volume":"118","author":"Fung","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0165","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s000590050009","article-title":"Molecular pathology and structural features of enteroviral replication. Toward understanding the pathogenesis of viral heart disease","volume":"25","author":"Klingel","year":"2000","journal-title":"Herz."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0170","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1253\/circj.CJ-16-0234","article-title":"Clinical features of acute and fulminant myocarditis in children- 2nd Nationwide Survey by Japanese Society of Pediatric Cardiology and Cardiac Surgery","volume":"80","author":"Matsuura","year":"2016","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0175","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jacc.2010.01.004","article-title":"Fulminant myocarditis associated with pandemic H1N1 influenza a virus in children","volume":"55","author":"Bratincsak","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0180","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/eurheartj\/ehaa286","article-title":"Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection","volume":"41","author":"Sala","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0185","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/ejhf.1738","article-title":"Viral genome search in myocardium of patients with fulminant myocarditis","volume":"22","author":"Veronese","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0190","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijcard.2019.07.025","article-title":"Diagnosis of immune checkpoint inhibitor-associated myocarditis: a systematic review","volume":"296","author":"Pradhan","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0195","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/j.jacc.2017.09.023","article-title":"Eosinophilic myocarditis: characteristics, treatment, and outcomes","volume":"70","author":"Brambatti","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0200","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","article-title":"Fulminant myocarditis with combination immune checkpoint blockade","volume":"375","author":"Johnson","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0205","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.amjcard.2008.07.041","article-title":"Usefulness of immunosuppression for giant cell myocarditis","volume":"102","author":"Cooper","year":"2008","journal-title":"Am. J. Cardiol."},{"issue":"Suppl. 2","key":"10.1016\/j.ijcard.2020.10.063_bb0210","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.2459\/JCM.0000000000000250","article-title":"Giant cell myocarditis successfully treated with antithymocyte globuline and extracorporeal membrane oxygenation for 21 days","volume":"17","author":"Ammirati","year":"2016","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"key":"10.1016\/j.ijcard.2020.10.063_bb0215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/CIRCHEARTFAILURE.112.969261","article-title":"Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression","volume":"6","author":"Kandolin","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0220","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac Sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0225","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ejhf.1319","article-title":"Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres","volume":"20","author":"Fussner","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0230","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMc1903064","article-title":"Alemtuzumab for immune-related myocarditis due to PD-1 therapy","volume":"380","author":"Esfahani","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0235","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1056\/NEJMc1901677","article-title":"Abatacept for severe immune checkpoint inhibitor-associated myocarditis","volume":"380","author":"Salem","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0240","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1056\/NEJM199508033330501","article-title":"A clinical trial of immunosuppressive therapy for myocarditis. The myocarditis treatment trial investigators","volume":"333","author":"Mason","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0245","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/01.CIR.89.1.252","article-title":"Gamma-globulin treatment of acute myocarditis in the pediatric population","volume":"89","author":"Drucker","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.10.063_bb0250","article-title":"Intravenous immunoglobulin for presumed viral myocarditis in children and adults","volume":"5","author":"Robinson","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0255","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/ejhf.1560","article-title":"Immunosuppression in inflammatory cardiomyopathy and parvovirus B19 persistence","volume":"21","author":"Tschope","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0260","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cardfail.2019.04.012","article-title":"Trends in the incidence of in-hospital mortality, cardiogenic shock, and utilization of mechanical circulatory support devices in myocarditis (Analysis of National Inpatient Sample Data, 2005\u20132014)","volume":"25","author":"Pahuja","year":"2019","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0265","first-page":"642","article-title":"First successful bridge to recovery with the Impella recover 100 left ventricular assist device for fulminant acute myocarditis","volume":"4","author":"Colombo","year":"2003","journal-title":"Ital. Heart J."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0270","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/eurheartj\/ehi411","article-title":"Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation","volume":"26","author":"Asaumi","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0275","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.athoracsur.2015.08.014","article-title":"Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients: a 5-year multi-institutional experience","volume":"101","author":"Lorusso","year":"2016","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0280","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1253\/circj.CJ-17-0549","article-title":"Early prediction model for successful bridge to recovery in patients with fulminant myocarditis supported with percutaneous Venoarterial extracorporeal membrane oxygenation - insights from the CHANGE PUMP study","volume":"82","author":"Sawamura","year":"2018","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0285","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12265-018-9820-2","article-title":"Mechanical unloading by fulminant myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA concepts","volume":"12","author":"Tschope","year":"2019","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0290","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations","volume":"72","author":"Ferreira","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0295","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary Management of Cardiogenic Shock: a scientific statement from the American Heart Association","volume":"136","author":"van Diepen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.10.063_bb0300","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijcard.2005.04.014","article-title":"Predictive factors of a fulminant course in acute myocarditis","volume":"109","author":"Lee","year":"2006","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0305","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0310","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of Cardiac Injury with Mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0315","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0320","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0325","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yjmcc.2020.08.008","article-title":"Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients","volume":"147","author":"Li","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0330","article-title":"Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia","author":"Yang","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0335","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2459\/JCM.0000000000000989","article-title":"Fulminant myocarditis triggered by OC43 subtype coronavirus: a disease deserving evidence-based care bundles","volume":"21","author":"Veronese","year":"2020","journal-title":"J. Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0340","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamacardio.2020.1096","article-title":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Inciardi","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0345","article-title":"Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin","author":"Hu","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0350","doi-asserted-by":"crossref","DOI":"10.1002\/ehf2.12912","article-title":"Takotsubo syndrome as a complication in a critically ill COVID-19 patient","author":"Bottiroli","year":"2020","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijcard.2020.10.063_bb0355","first-page":"1843","article-title":"Detection of SARS-CoV-2 in different types of clinical specimens","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2020.10.063_bb0360","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ejhf.1828","article-title":"Myocardial localization of coronavirus in COVID-19 cardiogenic shock","volume":"22","author":"Tavazzi","year":"2020","journal-title":"Eur. J. Heart Fail."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732034050X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732034050X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:49:10Z","timestamp":1759092550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752732034050X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":72,"alternative-id":["S016752732034050X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.10.063","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.10.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}